Development of preclinical candidate in the field of anaemia Evotec to provide integrated biology, chemistry and preclinical development activities Project worth in excess of EUR 5.5 million Hamburg, Germany - 2 February 2010: Evotec AG (F... - read more
Strategic alliance with CHDI aimed at accelerating efforts to develop drugs against Huntington's disease - Entails research revenue of up to US$ 37.5 million over the next three years One of the largest strategic drug disc...
- Evotec receives milestone from Ono for the progression of novel protease inhibitors into lead optimisation -
Hamburg, Germany / Abingdon, UK - 14 December 2009: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) today announced that it has... - read more